Startup Rana Therapeutics has named Art Krieg as its president and CEO.
Krieg was most recently an entrepreneur in residence at venture capital firm and Rana investor Atlas Venture. Before that, he served as head of Pfizer's oligonucleotide therapeutics unit.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
